Publication | Closed Access
The influence of hepatic impairment on the pharmacokinetics of the dipeptidyl peptidase IV (DPP-4) inhibitor vildagliptin
64
Citations
17
References
2007
Year
Liver PhysiologyPharmacologyHepatic ImpairmentHepatitisHepatotoxicityPharmacotherapyMedicineDrug-induced Liver InjuryPharmacokineticsInhibitor VildagliptinDipeptidyl Peptidase Iv
| Year | Citations | |
|---|---|---|
Page 1
Page 1